IN THIS ARTICLE

Citations

1. MacDiarmid SA, et al. (2008). Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: Randomized, double-blind, placebo-controlled study. Mayo Clinic Proceedings, 83(9): 1002–1010.

2. Kaplan SA, et al. (2006). Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. JAMA, 296(19): 2319–2328.

Other Works Consulted

• Appell RA, Winters JC (2007). Injection therapy for urinary incontinence. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 2272–2287. Philadelphia: Saunders Elsevier.

• Naumann M, et al. (2008). Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 70(19): 1707–1714.

• Nitti VW, Blaivas JG (2007). Urinary incontinence: Epidemiology, pathophysiology, evaluation, and management overview. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 2046–2078. Philadelphia: Saunders Elsevier.

• Ouslander JG (2008). Urinary incontinence. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 125–128. Philadelphia: Saunders Elsevier.